science
plus
.abes.fr
|
explorer
À propos de :
Avallone A.
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Avallone A.
familyName
Avallone
Given name
A.
is
relates
of
http://hub.abes.fr/oup/periodical/annonc/2003/volume_14/issue_10/101093annoncmdg402/authorship/6
http://hub.abes.fr/oup/periodical/annonc/2000/volume_11/issue_10/101023a1008375705484/authorship/10
http://hub.abes.fr/oup/periodical/annonc/1999/volume_10/issue_8/101023a1008339010655/authorship/4
http://hub.abes.fr/oup/periodical/annonc/2000/volume_11/issue_5/101023a1008339428733/authorship/4
http://hub.abes.fr/oup/periodical/annonc/2000/volume_11/issue_4/101023a1008308609978/authorship/5
http://hub.abes.fr/oup/periodical/annonc/2000/volume_11/issue_3/101023a1008319618638/authorship/5
http://hub.abes.fr/oup/periodical/annonc/2002/volume_13/issue_12/101093annoncmdf307/authorship/4
http://hub.abes.fr/oup/periodical/annonc/2001/volume_12/issue_2/101023a1008322415335/authorship/8
http://hub.abes.fr/oup/periodical/annonc/2002/volume_13/issue_9/101093annoncmdf240/authorship/8
is
Author
of
Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: A phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: A phase II study of the Southern Italy Cooperative Oncology Group (SICOG)
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases
Concurrent irinotecan and 5-fluorouracil plus levo-folinic acid given every other week in the first-line management of advanced colorectal carcinoma: A phase I study of the Southern Italy Cooperative Oncology Group
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma
Oxaliplatin and raltitrexed combined with leucovorin-modulated 5-fluorouracil i.v. bolus every two weeks: A dose finding study in advanced previously treated colorectal carcinoma
Biweekly irinotecan or raltitrexed plus 6S-leucovorin and bolus 5-fluorouracil in advanced colorectal carcinoma: A Southern Italy Cooperative Oncology Group phase II-III randomized trial
Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata